Celldex Therapeutics, Inc. 13F holders
253 funds reported a position in Celldex Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 85.8 million shares worth $3.19 billion. Against the quarter before, 42 opened a position, 105 added, 57 trimmed and 21 sold out; together they bought a net 11.5 million shares. The largest holders: Wellington Management Group LLP, BlackRock, Inc. and Kynam Capital Management, LP.
What each fund did in CLDX against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in CLDX in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 30 reported a position in Celldex Therapeutics, Inc.: 2 opened one, 9 added, 2 trimmed and 4 sold out, a net 1.1 million shares sold.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | -1,132,470 | 444,922 | trimmed | 13F |
| Y-Intercept (Hong Kong) Ltd | +43,719 | 75,976 | added | 13F |
| Ellsworth Advisors, LLC | +29,572 | 29,572 | new | 13F |
| Mirador Capital Partners LP | +12,213 | 193,267 | added | 13F |
| Values First Advisors, Inc. | +10,483 | 10,483 | new | 13F |
| Sterling Capital Management LLC | +1,854 | 2,376 | added | 13F |
| Hennion & Walsh Asset Management, Inc. | +681 | 47,794 | added | 13F |
| Abel Hall, LLC | +399 | 6,237 | added | 13F |
| Gamma Investing LLC | +341 | 697 | added | 13F |
| SJS Investment Consulting Inc. | +180 | 231 | added | 13F |
| Nisa Investment Advisors, LLC | +170 | 2,415 | added | 13F |
| Farther Finance Advisors, LLC | +71 | 287 | added | 13F |
| True Wealth Design, LLC | -6 | 34 | trimmed | 13F |
| PSP Research LLC | -13,000 | 0 | sold out | 13F |
| T3 Companies, LLC | -6,000 | 0 | sold out | 13F |
| Tsfg, LLC | -50 | 0 | sold out | 13F |
| Wealth Enhancement Trust Services, Inc. | -24 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Celldex Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 3.7 million shares worth $138.5 million, 0.0% of its reported book. Sold out: Citadel Advisors. In the quarter, 2 funds added or opened a position and 4 trimmed or sold out; together they sold a net 2.6 million shares, about $95.4 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 3,722,888 | $138.5 million | 0.0% | -26,160 | trimmed | 30 June 2026 | 13F |
| Geode Capital Management | 2,022,226 | $75.3 million | 0.0% | +334,152 | added | 30 June 2026 | 13F |
| Millennium Management | 1,170,787 | $43.6 million | 0.0% | -82,745 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 661,235 | $24.6 million | 0.0% | +524,220 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 117,217 | $4.4 million | 0.0% | -3,112,722 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 0 | $0 | 0.0% | -200,612 | exited | 30 June 2026 | 13F |
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 9,543,671 | 11.12% | $355.1 million | 0.06% | +983,195 | 13F |
| BlackRock, Inc. | 7,002,530 | 8.16% | $260.6 million | 0.00% | +1,632,645 | 13F |
| Kynam Capital Management, LP | 5,322,908 | 6.20% | $198.1 million | 10.95% | -517,659 | 13F |
| Price T Rowe Associates Inc. | 4,685,223 | 5.46% | $174.3 million | 0.02% | +2,598,891 | 13F |
| State Street Corp. | 3,900,427 | 4.55% | $145.1 million | 0.00% | +1,096,259 | 13F |
| FMR LLC | 3,722,888 | 4.34% | $138.5 million | 0.01% | -26,160 | 13F |
| Vanguard Capital Management LLC | 3,464,831 | 4.04% | $128.9 million | 0.00% | +503,936 | 13F |
| Deep Track Capital, LP | 2,939,151 | 3.43% | $109.4 million | 1.61% | +1,655,172 | 13F |
| Logos Global Management LP | 2,100,000 | 2.45% | $78.1 million | 3.36% | +1,650,000 | 13F |
| Geode Capital Management, LLC | 2,022,226 | 2.36% | $75.3 million | 0.00% | +334,152 | 13F |
| Eversept Partners, LP | 1,785,941 | 2.08% | $66.5 million | 3.62% | -2,075 | 13F |
| Goldman Sachs Group Inc. | 1,615,343 | 1.88% | $60.1 million | 0.01% | +626,927 | 13F |
| Assenagon Asset Management S.A. | 1,577,392 | 1.84% | $58.7 million | 0.04% | 13F | |
| Commodore Capital LP | 1,350,000 | 1.57% | $50.2 million | 2.99% | -1,346,616 | 13F |
| Bellevue Group AG | 1,200,000 | 1.40% | $44.7 million | 0.94% | no change | 13F |
| Baker Bros. Advisors LP | 1,182,611 | 1.38% | $44.0 million | 0.22% | +517,241 | 13F |
| Millennium Management LLC | 1,170,787 | 1.36% | $43.6 million | 0.03% | -82,745 | 13F |
| Dimensional Fund Advisors LP | 1,073,985 | 1.25% | $40.0 million | 0.01% | +14,451 | 13F |
| American Century Companies Inc. | 1,042,395 | 1.21% | $38.8 million | 0.02% | +186,085 | 13F |
| Eventide Asset Management, LLC | 1,037,000 | 1.21% | $38.6 million | 0.52% | no change | 13F |
| Novo Holdings A/s | 1,025,000 | 1.19% | $38.1 million | 2.21% | -175,000 | 13F |
| Elmind Capital, LP | 990,000 | 1.15% | $36.8 million | 9.26% | +125,000 | 13F |
| Driehaus Capital Management LLC | 989,442 | 1.15% | $36.8 million | 0.21% | new | 13F |
| Fisher Asset Management, LLC | 985,677 | 1.15% | $36.7 million | 0.01% | -27,971 | 13F |
| Pictet Asset Management Holding SA | 917,408 | 1.07% | $34.1 million | 0.03% | -6,288 | 13F |
| Foresite Capital Management VI LLC | 879,713 | 1.03% | $32.7 million | 5.09% | +563,800 | 13F |
| Vanguard Portfolio Management LLC | 863,536 | 1.01% | $32.1 million | 0.00% | +234,284 | 13F |
| Northern Trust Corp. | 719,647 | 0.84% | $26.8 million | 0.00% | +142,380 | 13F |
| Woodline Partners LP | 700,830 | 0.82% | $26.1 million | 0.08% | +200,703 | 13F |
| Affinity Asset Advisors, LLC | 700,000 | 0.82% | $26.0 million | 1.29% | +200,000 | 13F |
| Rock Springs Capital Management LP | 699,146 | 0.81% | $26.0 million | 1.27% | +48,876 | 13F |
| Two Sigma Investments, LP | 661,235 | 0.77% | $24.6 million | 0.02% | +524,220 | 13F |
| Charles Schwab Investment Management Inc. | 655,954 | 0.76% | $24.4 million | 0.00% | +110,468 | 13F |
| Algert Global LLC | 647,836 | 0.76% | $24.1 million | 0.29% | +432,677 | 13F |
| ADAR1 Capital Management, LLC | 619,542 | 0.72% | $23.1 million | 1.09% | +191,726 | 13F |
| Bank of America Corp. | 607,195 | 0.71% | $22.6 million | 0.00% | -101,452 | 13F |
| Panagora Asset Management Inc. | 572,538 | 0.67% | $21.3 million | 0.07% | +430,211 | 13F |
| Nuveen, LLC | 568,460 | 0.66% | $21.2 million | 0.01% | +366,511 | 13F |
| Vanguard Fiduciary Trust Co. | 552,973 | 0.64% | $20.6 million | 0.01% | +123,376 | 13F |
| 5AM Venture Management, LLC | 497,270 | 0.58% | $18.5 million | 6.43% | no change | 13F |
| Federated Hermes, Inc. | 492,893 | 0.57% | $18.3 million | 0.03% | new | 13F |
| UBS Group AG | 481,997 | 0.56% | $17.9 million | 0.00% | +185,027 | 13F |
| Candriam S.C.A. | 481,125 | 0.56% | $17.9 million | 0.08% | +202,237 | 13F |
| Ikarian Capital, LLC | 478,500 | 0.56% | $17.8 million | 2.92% | +17,253 | 13F |
| Braidwell LP | 436,646 | 0.51% | $16.2 million | 0.62% | -919,436 | 13F |
| Redmile Group, LLC | 433,921 | 0.51% | $16.1 million | 1.08% | +172,413 | 13F |
| Citigroup Inc. | 404,703 | 0.47% | $15.1 million | 0.01% | +187,368 | 13F |
| Palo Alto Investors LP | 399,856 | 0.47% | $14.9 million | 2.06% | +103,448 | 13F |
| TSP Capital Management Group, LLC | 371,127 | 0.43% | $13.8 million | 3.30% | new | 13F |
| PFM Health Sciences, LP | 342,751 | 0.40% | $12.8 million | 1.11% | +17,794 | 13F |
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on CLDX
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Puts | 33,900 | $1.3 million | 30 June 2026 | 13F |
| Citadel Advisors | Calls | 24,000 | $893,040 | 30 June 2026 | 13F |
| Point72 Asset Management | Calls | 1,200 | $44,652 | 30 June 2026 | 13F |
| Point72 Asset Management | Puts | 1,000 | $37,210 | 30 June 2026 | 13F |
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 7 October 2026 | 13G/A | FMR LLC and 3 others | 8.4 million | 10.7% | 30 September 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 14 August 2026 | 13G/A | Kynam Capital Management, LP and 5 others | 0 | 6.8% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 14 August 2026 | 13G | T. Rowe Price Associates, Inc. and 1 other | 4.7 million | 6.0% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G/A | Kynam Capital Management, LP and 5 others | 0 | 8.8% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G/A | Bellevue Group AG and 3 others | 1.2 million | 1.5% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 May 2026 | 13G | State Street Corporation and 1 other | 2.8 million | 4.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 6 May 2026 | 13G/A | FMR LLC and 3 others | 3.7 million | 5.6% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 3.4 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 10 March 2026 | 13G/A | Point72 Asset Management, L.P. and 5 others | 1.8 million | 2.6% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 10 February 2026 | 13G/A | Wellington Management Group LLP and 7 others | 8.1 million | 12.2% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 9 February 2026 | 13G | State Street Corporation and 1 other | 3.4 million | 5.1% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Commodore Capital LP and 3 others | 3.0 million | 4.6% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 November 2025 | 13G | Bellevue Group AG and 3 others | 3.6 million | 5.4% | 18 August 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | T. Rowe Price Associates, Inc. and 1 other | 2.4 million | 3.6% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 7 November 2025 | 13G/A | Wellington Management Group LLP and 7 others | 7.4 million | 11.1% | 31 October 2025 | passive, institutional (13d-1(b)) | EDGAR |
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 30 September 2026 | 2 | $31.64 | SEC |
| 23 September 2026 | 20,161 | $33.51 | SEC |
| 15 September 2026 | 24 | $39.18 | SEC |
| 1 September 2026 | 54,085 | $39.63 | SEC |
| 18 August 2026 | 1,202 | $41.92 | SEC |